Home › NDC Lookup › RxCUI directory › RxCUI 1005856

Sulfacetamide sodium 100 MG/ML / sulfur 50 MG/ML Topical Lotion — RxCUI 1005856

RxNorm drug concept · Semantic clinical drug
RxCUI 1005856 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 8 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1005856
Official nameSulfacetamide sodium 100 MG/ML / sulfur 50 MG/ML Topical Lotion
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assulfacetamide sodium 10 % / sulfur 5 % Topical Lotion; sulfacetamide sodium 10 % / sulfur 5 % Topical Suspension
FDA products mapped6
Package NDCs mapped8
Reported Medicaid activity (SDUD)124 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sulfacetamide Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's an antibiotic drop that targets bacterial infections on the surface of your eye. The most common reason it's prescribed is conjunctivitis — what most people call pink eye — ca...
  • What is this eye drop actually treating?
  • At the start of treatment, you'll use them quite frequently — typically every two to three hours. As your eye starts to get better, your doctor will usually have you space the dose...
  • How often do I need to put the drops in?
📖 Read our full Sulfacetamide Ophthalmic guide →

🕸️ Concept Web — How Sulfacetamide sodium 100 MG/ML / sulfur 50 MG/ML... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sulfacetamide sodium 100 MG/ML / sulfur 50 MG/ML Topical Lotion RxCUI 1005856

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Sulfacetamide 10169
    • Sulfur 10223
    • Sulfacetamide / sulfur 690740
    • Sulfacetamide sodium 82101
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sulfacetamide / sulfur Topical Lotion 377818
    • Sulfacetamide sodium / sulfur Topical Lotion 2649118
    • Sulfacetamide / sulfur Topical Product 1162333
    • Sulfacetamide sodium / sulfur Topical Product 2662055
    • Topical Lotion 316983
    • Topical Product 1151122
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Sulfacetamide sodium 100 MG/ML 832863
    • Sulfur 50 MG/ML 340033

Showing up to 8 concepts per family — 12 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sulfacetamide sodium 100 MG/ML SCDC · 832863
  • Sulfur 50 MG/ML SCDC · 340033
  • Sulfacetamide / sulfur Topical Lotion SCDF · 377818
  • Sulfacetamide sodium / sulfur Topical Lotion SCDFP · 2649118
  • Sulfacetamide / sulfur Topical Product SCDG · 1162333
  • Sulfacetamide sodium / sulfur Topical Product SCDGP · 2662055

📦 FDA Products & Package NDCs

6 products · 8 package NDCs
8 package NDCs map to RxCUI 1005856 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24470-0932-01 1 BOTTLE, PLASTIC in 1 CARTON (24470-932-01) / 25 g in 1 BO... SULFACETAMIDE SODIUM, SULFUR Cintex Services, LLC 2024-01-23
24470-0933-01 1 BOTTLE, PLASTIC in 1 CARTON (24470-933-01) / 30 g in 1 BO... SULFACETAMIDE SODIUM, SULFUR Cintex Services, LLC 2024-01-23
24470-0934-01 1 BOTTLE, PLASTIC in 1 CARTON (24470-934-01) / 30 g in 1 BO... SULFACETAMIDE SODIUM, SULFUR Cintex Services, LLC 2024-01-23
24470-0934-02 1 BOTTLE, PLASTIC in 1 CARTON (24470-934-02) / 60 g in 1 BO... SULFACETAMIDE SODIUM, SULFUR Cintex Services, LLC 2024-01-23
44523-0602-01 1 BOTTLE, PLASTIC in 1 CARTON (44523-602-01) / 25 g in 1 BO... SODIUM SULFACETAMIDE AND SULFUR BioComp Pharma, Inc. 2011-04-30
44523-0604-01 30 g in 1 BOTTLE, PLASTIC (44523-604-01) SODIUM SULFACETAMIDE, SULFUR BioComp Pharma, Inc. 2011-06-04
44523-0607-01 30 g in 1 BOTTLE, PLASTIC (44523-607-01) SODIUM SULFACETAMIDE AND SULFUR BioComp Pharma, Inc. 2011-06-04
44523-0607-02 60 g in 1 BOTTLE, PLASTIC (44523-607-02) SODIUM SULFACETAMIDE AND SULFUR BioComp Pharma, Inc. 2011-06-04
Observed labelers: BioComp Pharma, Inc. (4) · Cintex Services, LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.